Empowered Funds
LENZ icon

Empowered Funds’s LENZ Therapeutics LENZ Stock Holding History

Empowered Funds’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$156K Buy
+40,549
New +$202K ﹤0.01% 2338

Other funds holding LENZ

Alpha Wave Global
Alpha Wave Global New York $4.27B AUM 12.79% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Versant Venture Management
Versant Venture Management San Francisco, California $109M AUM 43.78% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Blue Owl Capital Holdings
Blue Owl Capital Holdings New York $548M AUM 35.34% 1-Year Est. Return
C WorldWide Group
C WorldWide Group Copenhagen, Denmark $3.96B AUM 10.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Empowered Funds's LENZ Position: Q3 2026 in Review

Empowered Funds opened a new position in LENZ Therapeutics (LENZ) in Q3 2026: 40,549 shares worth $156K. The stake represents ﹤0.01% of the portfolio and ranks #2338 among its holdings.

91 funds tracked by Wall St. Rank hold LENZ as of Q3 2026.

  • Empowered Funds held 40,549 shares of LENZ Therapeutics worth $156K as of Q3 2026.
  • LENZ Therapeutics was a new Empowered Funds position in Q3 2026.
  • LENZ Therapeutics made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2338 holding.
  • 91 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.